Intravitreal triamcinolone in retinal vasculitis - Case report;Triancinolona intravítrea em vasculite retiniana - Relato de caso

Arquivos Brasileiros de Oftalmologia

Volumn 67, Issue 6, 2004, Pages 953-956

  De Godoy, Glaucio ^a   Finamor, Luciana Peixoto ^a   Andrade, Rafael ^a   Muccioli, Cristina ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Case report; Intralesional injections; Retinal vasculitis drug therapy; Triamcinolone adverse effects; Triamcinolone therapeutic use; Uveitis

Indexed keywords

EID: 33846838566     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/s0004-27492004000600021     Document Type: Article

References (14)

1. Benítez Del Castillo Sánchez JM, Garcia Sánchez J. Intravitreal injection of triamcinolone acetonide in non infectious uveitis. Arch Soc Esp Oftalmol. 2001;76(11):661-664 Spanish.
2. Degenring RF, Jonas JB. Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis. Br J Ophthalmol. 2003;87(3):361.
3. Penn JS, Rajaratnam VS, Collier RJ, Clark AF. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2001;42(1):283-290
4. Danis RP, Bingaman DP, Yang Y, Ladd B. Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology. 1996;103(12):2099-2104
5. Nauck M, Karakiulakis G, Perruchoud AP, Papakonstantinou E, Roth M. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol. 1998;341(2-3):309-315
6. Martidis A, Miller DG, Ciulla TA, Danis RP, Moorthy RS. Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization. J Ocul Pharmacol Ther. 1999;15(5):425-428
7. Jonas JB, Hayler JK, Söfker A, Panda-Jonas S. Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone. J Glaucoma. 2001; 10(4):284-287
8. George RK, Walton C, Whitcup SM, Nussenblatt RB. Primary retinal vasculitis. System associations and diagnostic evaluation. Ophthalmology. 1996; 103:384-389
9. Machemer R, Sugita G, Tano Y. Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc. 1979;77:171-180
10. Gillies MC, Simpson JM, Luo W, Penfold P, Hunyor AB, Chua W, et al. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Arch Ophthalmol. 2003;121(5):667-673
11. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol. 2003;87(1):24-27
12. Benz MS, Murray TG, Dubovy SR, Katz RS, Eifrig CW. Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone. Arch Ophthalmol. 2003;121(2):271-273
13. Beer PM, Bakri SJ, Singh RJ, Liu W, Peters GB, Miller M. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology. 2003;110(4):681-686
14. Jaffe GJ, Ben-Nun J, Guo H, Dunn JP, Ashton P. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. Ophthalmology. 2000; 107(11):2024-2033